UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation
Authors:
Open Access
- 29 July 2011
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 130 (12) , 2771-2782
Abstract
Ursodeoxycholic acid (UDCA) attenuates colon carcinogenesis in humans and in animal models by an unknown mechanism. We investigated UDCA effects on normal intestinal epithelium in vivo and in vitro to identify the potential chemopreventive mechanism. Feeding of mice with 0.4% UDCA reduced cell proliferation to 50% and suppressed several potential proproliferatory genes including insulin receptor substrate 1 (Irs‐1). A similar transcriptional response was observed in the rat intestinal cell line IEC‐6 which was then used as an in vitro model. UDCA slowed down the proliferation of IEC‐6 cells and induced sustained hyperphosphorylation of ERK1/ERK2 kinases which completely inhibited the proproliferatory effects of EGF and IGF‐1. The hyperphosphorylation of ERK1 led to a transcriptional suppression of the Irs‐1 gene. Both, the hyperphosphorylation of ERK as well as the suppression of Irs‐1 were sufficient to inhibit proliferation of IEC‐6 cells. ERK1/ERK2 inhibition in vitro or ERK1 elimination in vitro or in vivo abrogated the antiproliferatory effects of UDCA. We show that UDCA inhibits proliferation of nontransformed intestinal epithelial cells by inducing a sustained hyperphosphorylation of ERK1 kinase which slows down the cell cycle and reduces expression of Irs‐1 protein. These data extend our understanding of the physiological and potentially chemopreventive effects of UDCA and identify new targets for chemoprevention.Keywords
This publication has 37 references indexed in Scilit:
- Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFRBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene, 2007
- Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescenceInternational Journal of Cancer, 2006
- MAPK signal specificity: the right place at the right timeTrends in Biochemical Sciences, 2006
- Prevention of colitis‐associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acidInternational Journal of Cancer, 2006
- Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma RecurrenceJNCI: Journal of the National Cancer Institute, 2005
- Ursodeoxycholic Acid Therapy and the Risk of Colorectal Adenoma in Patients With Primary Biliary Cirrhosis: An Observational StudyHepatology, 2003
- Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitisGastroenterology, 2003
- Persistent ERK Phosphorylation Negatively Regulates cAMP Response Element-binding Protein (CREB) Activity via Recruitment of CREB-binding Protein to pp90RSKJournal of Biological Chemistry, 2003
- Spatial Analysis of Key Signaling Proteins by High-content Solid-phase Cytometry in Hep3B Cells Treated with an Inhibitor of Cdc25 Dual-specificity PhosphatasesJournal of Biological Chemistry, 2001